BrickBio Debuts Powerful Advantage of Novel ADCs, Protein Origami, and Synthetic Virology at 2022 AACR
/PRNewswire/ -- BrickBio, the leader in RNA facilitated site-specific conjugation for novel protein therapeutics, will be presenting an invited poster at the...
Source: prnewswire.com